A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer - Suzuki, Mai; Uchibori, Ken; Oh-hara, Tomoko; Nomura, Yumi; Suzuki, Ryusei; Takemoto, Ai; Araki, Mitsugu; Matsumoto, Shigeyuki; Sagae, Yukari; Kukimoto-Niino, Mutsuko; Kawase, Yusuke; Shirouzu, Mikako; et al. (npj Precision Oncology, 2024)